Department of Public Health, University of Naples Federico II, Naples, Italy.
Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, 80131, Naples, Italy.
Arch Gynecol Obstet. 2024 Nov;310(5):2569-2576. doi: 10.1007/s00404-024-07707-8. Epub 2024 Sep 2.
Minimally invasive surgery is considered the gold standard for the treatment of gynecological diseases. Our study aims to assess the effectiveness of the new concept of ultra-low-impact laparoscopy as a combination of low-impact laparoscopy, consisting in the use of miniaturized instruments through 3-5mm ports and low-pressure pneumoperitoneum, with regional anesthesia to evaluate the perioperative outcomes.
A cross-sectional study was performed from May 2023 to December 2023, to enroll 26 women affected by benign gynecological disease and threated by mini-invasive surgical approach. The surgical procedures were performed following the low-impact laparoscopy protocol and the regional anesthesia protocol. The postoperative pain, nausea, and vomiting and the antiemetic/analgesic intake were evaluated. Postoperative surgical and anesthesiological variables were analyzed.
Operative time was within 90 min (41.1 ± 17.1 mean ± standard deviation (SD)) and no conversion to laparotomy or general anesthesia was required. According to VAS score, the postoperative pain during the whole observation time was less than 3 (mean). Faster resumption of bowel motility (6.5 ± 2.1 mean ± SD) and women's mobilization (3.1 ± 0.7 mean ± SD) were observed as well as low incidence of post-operative nausea and vomit. Early discharge and patient's approval were recorded. Intraoperatively pain score was assessed on Likert scale during all stages.
Ultra-low-impact laparoscopy showed to provide a satisfying recovery experience for patients in terms of short hospital stays, cosmetic result, and pain relief, without compromising surgical outcomes. The encouraging results lead us to recruit a greater number of patients to validate our technique as a future well-established produce.
微创手术被认为是治疗妇科疾病的金标准。我们的研究旨在评估新的超低冲击腹腔镜概念的有效性,该概念将低冲击腹腔镜(通过 3-5mm 端口和低压气腹使用微型仪器)与区域麻醉相结合,以评估围手术期结果。
一项从 2023 年 5 月至 2023 年 12 月进行的横断面研究,共纳入 26 名患有良性妇科疾病并接受微创外科治疗的女性。手术按照低冲击腹腔镜方案和区域麻醉方案进行。评估术后疼痛、恶心、呕吐以及止吐/镇痛药物的摄入情况。分析术后手术和麻醉学变量。
手术时间在 90 分钟内(41.1±17.1 均值±标准差),无需转为剖腹手术或全身麻醉。根据视觉模拟评分(VAS),整个观察期间的术后疼痛小于 3(均值)。观察到更快的肠道蠕动恢复(6.5±2.1 均值±标准差)和女性的活动能力恢复(3.1±0.7 均值±标准差),以及术后恶心和呕吐的发生率较低。记录了早期出院和患者的认可。术中疼痛评分在所有阶段均采用李克特量表进行评估。
超低冲击腹腔镜为患者提供了令人满意的恢复体验,具有较短的住院时间、美容效果和缓解疼痛,而不会影响手术结果。令人鼓舞的结果促使我们招募更多的患者来验证我们的技术,作为未来成熟的产品。